Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India

REFERENCES

• Allen, S., T. Bade, D. Hatsukami, and B. Center. 2010. Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse. Nicotine & Tobacco Research 10 (1):35–45. doi:10.1080/14622200701705076.
   Web of Science ®Google Scholar
• Araujo, R. B., M. S. Oliveira, and A. Mansur. 2006. Brazilian validation of the questionnaire of smoking urges. Cadernos de Saúde Pública 22:2157–67. doi:10.1590/S0102-311X2006001000022.
   PubMedGoogle Scholar
• Benowitz, N. L., P. Jacob, K. Ahijevych, M. J. Jarvis, S. Hall, J. LeHouezec, and W. Velicer. 2002. Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research 4:149–59. doi:10.1080/14622200210123581.
   PubMedGoogle Scholar
• Boyle, R. G. 1992. Smokeless tobacco cessation with nicotine replacement: A randomized clinical trial. Dissertation Abstracts International 54 (3–A):825.
   Google Scholar
• Cox, L. S., S. T. Tiffany, and A. G. Christen. 2001. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research 3 (1):7–16. doi:10.1080/14622200020032051.
   PubMedGoogle Scholar
• Critchley, J. A., and B. Unal. 2003. Health effects associated with smokeless tobacco: A systematic review. Thorax 58 (5):435–43. doi:10.1136/thorax.58.5.435.
   PubMed Web of Science ®Google Scholar
• Dale L. C., J. O. Ebbert, E. D. Glover, I. T. Croghan, D. R. Schroeder, H. H. Severson and R. D. Hurt. 2007. Bupropion SR for the treatment of smokeless tobacco use. Drug Alcohol Dependency 90:56–63. doi:10.1016/j.drugalcdep.2007.02.008
   PubMed Web of Science ®Google Scholar
• Dikshit, R., and S. Kanhere. 2000. Tobacco habits and risk of lung, oropharyngeal and oral cavity cancer: A population-based case-control study in Bhopal. India. International Journal of Epidemiology 29:609–14. doi:10.1093/ije/29.4.609.
   PubMed Web of Science ®Google Scholar
• Ebbert, J. O., I. T. Croghan, H. H. Severson, D. R. Schroeder, and J. T. Hays. 2011. A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States. Nicotine & Tobacco Research 13 (9):820–26. doi:10.1093/ntr/ntr078.
   PubMed Web of Science ®Google Scholar
• Ebbert, J. O., V. Montori, K. S. Vickers, P. C. Erwin, L. C. Dale, and L. F. Stead. 2007. Interventions for smokeless tobacco use cessation. Cochrane Database of Systemic Reviews 4:CD004306. doi: 10.1002/14651858.CD004306.pub3.
   Web of Science ®Google Scholar
• Ebbert, J. O., C. A. Patten, and D. R. Schroeder. 2006. The Fagerström test for nicotine dependence-smokeless tobacco (FTND-ST). Addictive Behaviors 31:1716–21. doi:10.1016/j.addbeh.2005.12.015.
   PubMed Web of Science ®Google Scholar
• Fagerström, K., H. Gilljam, M. Metcalfe, S. Tonstad, and M. Messig. 2010. Stopping smokeless tobacco with varenicline: Randomised double blind placebo controlled trial. British Medical Journal 6 (341):c6549. doi:10.1136/bmj.c6549.
   Web of Science ®Google Scholar
• Fiore, M. C., W. C. Bailey, S. J. Cohen, S. F. Dorfman, M. G. Goldstein, E. R. Gritz, and M. E. Wewers. 2000. Treating tobacco use and dependence. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
   Google Scholar
• Foulds, J., M. B. Steinberg, J. M. Williams, and D. M. Ziedonis. 2006. Developments in pharmacotherapy for tobacco dependence: Past, present and future. Drug and Alcohol Review 25 (1):59–71. doi:10.1080/09595230500459529.
   PubMed Web of Science ®Google Scholar
• Franceschi, S., E. Bidoli, R. Herrero, and N. Muñoz. 2000. Comparison of cancers of the oral cavity and pharynx worldwide: Etiological clues. Oral Oncology 36:106–15. doi:10.1016/S1368-8375(99)00070-6.
   PubMed Web of Science ®Google Scholar
• Global Adult Tobacco Survey. 2010. GATS India report 2009- 2010. Mumbai: International Institute for Population Sciences (IIPS) and New Delhi: Ministry of Health and Family Welfare. http://www.who.int/tobacco/370surveillance/gats_india/en/index.html ( accessed December 15, 2014).
   Google Scholar
• Gonzales, D., S. I. Rennard, M. Nides, C. Oncken, S. Azoulay, C. B. Billing, and Varenicline Phase 3 Study Group. 2006. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. Journal of the American Medical Association 296:47–55. http://www.ncbi.nlm.nih.gov/pubmed/16820546
   Google Scholar
• Guillin, O., M. O. Krebs, M. C. Bourdel, J. P. Olie, H. Loo, and M. F. Poirier. 2000. Validation of the French translation and factorial structure of the Tiffany and Drobes smoking urge questionnaire. Encephale 26:27–31.
   PubMed Web of Science ®Google Scholar
• Hatsukami, D. K., M. Grillo, R. Boyle, S. Allen, J. Jensen, R. Bliss, and S. Brown. 2000. Treatment of spit tobacco users with transdermal nicotine system and mint snuff. Journal of Consulting and Clinical Psychology 68:241–49. doi:10.1037/0022-006X.68.2.241.
   PubMed Web of Science ®Google Scholar
• Hatsukami, D. K., J. Jensen, S. Allen, M. Grillo, and R. Bliss. 1996. Effects of behavioral and pharmacological treatment on smokeless tobacco users. Journal of Consulting and Clinical Psychology 64:153–61. doi:10.1037/0022-006X.64.1.153.
   PubMed Web of Science ®Google Scholar
• Hughes, J., and D. K. Hatsukami. 1998. Errors in using tobacco withdrawal scale. Tobacco Control 7 (1):92–93. doi:10.1136/tc.7.1.92a.
   PubMed Web of Science ®Google Scholar
• Hughes, J. R. 1992. Tobacco withdrawal in self-quitters. Journal of Consulting and Clinical Psychology 60 (5):689–97. doi:10.1037/0022-006X.60.5.689.
   PubMed Web of Science ®Google Scholar
• Hughes, J. R. 2007. Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine & Tobacco Research 9:315–27. doi:10.1080/14622200701188919.
   PubMed Web of Science ®Google Scholar
• Hughes, J. R., S. W. Gust, K. Skoog, R. M. Keenan, and J. W. Fenwick. 1991. Symptoms of tobacco withdrawal: A replication and extension. Archives of General Psychiatry 48 (1):52–59. doi:10.1001/archpsyc.1991.01810250054007.
   PubMed Web of Science ®Google Scholar
• Hughes, J. R., and D. Hatsukami. 1986. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 43 (3):289–94. doi:10.1001/archpsyc.1986.01800030107013.
   PubMed Web of Science ®Google Scholar
• Hughes, J. R., D. K. Hatsukami, R. W. Pickens, D. Krahn, S. Malin, and A. Luknic. 1984. Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology (Berl) 83 (1):82–87. doi:10.1007/BF00427428.
   PubMed Web of Science ®Google Scholar
• Jain, R., S. Jhanjee, V. Jain, T. Gupta, S. Mittal, P. Goelz, E. P. Wileyto, and R. A. Schnoll. 2014. A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India. Nicotine & Tobacco Research 16 (1):50–57. doi:10.1093/ntr/ntt115.
   PubMed Web of Science ®Google Scholar
• Jorenby, D. E., J. T. Hays, N. Rigotti, S. Azoulay, E. Watsky, K. E. Williams, and K. R. Reeves. 2006. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of American Medical Association 296:56–63. doi:10.1001/jama.296.1.56.
   PubMed Web of Science ®Google Scholar
• Killen, J. D., and S. P. Fortmann. 1997. Craving is associated with smoking relapse: Findings from three prospective studies. Experimental and Clinical Psychopharmacology 5 (2):137–42. doi:10.1037/1064-1297.5.2.137.
   PubMed Web of Science ®Google Scholar
• Kim, S. S., E. E. Gulick, S.-H. Kim, and H.-G. Seo. 2007. Psychometric properties of the Minnesota nicotine withdrawal scale: A Korean version. Journal of Nursing Measurement 15:121–32. doi:10.1891/106137407782156354.
   PubMedGoogle Scholar
• McCarthy, D. E., T. M. Piasecki, M. C. Fiore, and T. B. Baker. 2006. Life before and after quitting smoking: An electronic diary study. Journal of Abnormal Psychology 115:454–66. doi:10.1037/0021-843X.115.3.454.
   PubMed Web of Science ®Google Scholar
• Moore, S. R., N. W. Johnson, A. M. Pierce, and D. F. Wilson. 2000. The epidemiology of tongue cancer: A review of global incidence. Oral Diseases 6:75–84. doi:10.1111/j.1601-0825.2000.tb00105.x.
   PubMed Web of Science ®Google Scholar
• Murthy, M. 2009. Clinic based cessation programs in India: The evidence and what it calls for. 14th World Conference on Tobacco or Health. March 8-12, 2009. Mumbai, India. http://www.14wctoh.org/abstract/abs_detail.asp?AbstractID=1026 ( accessed December 15, 2014).
   Google Scholar
• Oishi, S., E. Diener, C. Napa Scollon, and R. Biswas-Diener. 2004. Cross-situational consistency of affective experiences across cultures. Journal of Personality and Social Psychology 86:460–72. doi:10.1037/0022-3514.86.3.460.
   PubMed Web of Science ®Google Scholar
• Patterson, F., C. Jepson, A. A. Strasser, J. Loughead, K. A. Perkins, R. C. Gur, J. M. Frey, S. Siegel, and C. Lerman. 2009. Varenicline improves mood and cognition during smoking abstinence. Biological Psychiatry 65 (2):144–49. doi:10.1016/j.biopsych.2008.08.028.
   PubMed Web of Science ®Google Scholar
• Rollema, H., J. W. Coe, L. K. Chambers, R. S. Hurst, S. M. Stahl, and K. E. Williams. 2007. Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation. Trends in Pharmacological Sciences 28:316–25. doi:10.1016/j.tips.2007.05.003.
   PubMed Web of Science ®Google Scholar
• Sapkota, A., V. Gajalakshmi, D. H. Jetly, S. Roychowdhury, R. P. Dikshit, P. Brennan, and P. Boffetta. 2007. Smokeless tobacco and increased risk of hypopharyngeal and laryngeal cancers: A multicenteric case-control study from India. International Journal of Cancer 121 (8):1793–98. doi:10.1002/ijc.22832.
   PubMed Web of Science ®Google Scholar
• Severson, H. H. 2003. What have we learned from 20 years of research on smokeless tobacco cessation? The American Journal of the Medical Sciences 326:206–11. http://www.wohfkidsconnect.com/site_i/PDF/20-Years.pdf
   Google Scholar
• Tonstad, S., P. Tonnesen, P. Hajek, K. E. Williams, C. B. Billing, and K. Reeves. 2006. Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial. Journal of American Medical Association 296 (1):64–71. doi:10.1001/jama.296.1.64.
   PubMed Web of Science ®Google Scholar
• Vora, A. R., C. M. Yeoman, and J. P. Hayter. 1997. Alcohol, tobacco and paan use and understanding of oral cancer risk among Asian men in Leicester. British Dental Journal 188:441–51. doi:10.1038/sj.bdj.4800506.
   Google Scholar
• Watson, D., L. A. Clark, and A. Tellegen. 1988. Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology 54 (6):1063–70. doi:10.1037/0022-3514.54.6.1063.
   PubMed Web of Science ®Google Scholar
• West, R. 2005. Defining and assessing nicotine dependence in humans. In Understanding Nicotine and Tobacco Addiction, ed. G. Bock and J. Goode, 36–51. London: Wiley.
   Google Scholar
• West, R., M. Ussher, M. Evans, and M. Rashid. 2006. Assessing DSM-IV nicotine withdrawal symptoms: A comparison and evaluation of five different scales. Psychopharmacology (Berl) 184:619–27. doi:10.1007/s00213-005-0216-z.
   PubMed Web of Science ®Google Scholar
• Znaor, A., P. Brennan, V. Gajalakshmi, A. Mathew, V. Shanta, C. Varghese, and P. Boffetta. 2003. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. International Journal of Cancer 105 (5):681–86. doi:10.1002/ijc.11114.
   PubMed Web of Science ®Google Scholar